<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">epilepsia</journal-id><journal-title-group><journal-title xml:lang="en">Epilepsy and paroxysmal conditions</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпилепсия и пароксизмальные состояния</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-8333</issn><issn pub-type="epub">2311-4088</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2077-8333.2019.11.4.312-320</article-id><article-id custom-type="elpub" pub-id-type="custom">epilepsia-498</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Is it possible to predict the treatment efficacy in adult patients with focal epilepsy?</article-title><trans-title-group xml:lang="ru"><trans-title>Можно ли предсказать эффективность лечения фокальных эпилепсий у взрослых?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2050-7258</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фирсов</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Firsov</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фирсов Константин Владимирович – к.псх. н., невролог</p></bio><bio xml:lang="en"><p>Konstantin V. Firsov – MD, PhD, Neurologist</p></bio><email xlink:type="simple">firsovkonst@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7117-7423</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Амирханян</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Amirhanyan</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Амирханян Мхитар Грантович – невролог</p></bio><bio xml:lang="en"><p>Mhitar G. Amirhanyan – MD, Neurologist</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2988-5706</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Котов Алексей Сергеевич – д.м.н., заведующий неврологическим отделением по разделу «Наука», профессор кафедры неврологии</p></bio><bio xml:lang="en"><p>Aleksei S. Kotov – MD, PhD, Head of the Department of Neurology, Professor at the Department of Neurology</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение здравоохранения Московской области «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Regional Research and Clinical Institute (MONIKI)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>11</day><month>01</month><year>2020</year></pub-date><volume>11</volume><issue>4</issue><fpage>312</fpage><lpage>320</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Firsov K.V., Amirhanyan M.G., Kotov A.S., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Фирсов К.В., Амирханян М.Г., Котов А.С.</copyright-holder><copyright-holder xml:lang="en">Firsov K.V., Amirhanyan M.G., Kotov A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epilepsia.su/jour/article/view/498">https://www.epilepsia.su/jour/article/view/498</self-uri><abstract><p>The aim was to determine the factors impacting the treatment efficacy in patients with focal epilepsy.</p><sec><title>Materials and methods</title><p>Materials and methods. This was a prospective, comparative, observational study conducted in real clinical practice. We adhered to the following inclusion criteria: age over 18 years; history of two or more epileptic seizures with the focal onset; the presence of epileptic seizures at the time of the initial examination. The exclusion criteria were the history of nonepileptic seizures of any etiology and the inability to perform MRI and/or EEG. The primary and the follow-up examinations were separated by 3-12 months. Eighty three patients with focal epilepsy who met the inclusion criteria (37 men and 46 women aged 19 to 70 years) were examined. The examination included history taking, analysis of the seizure diary, clinical and neurological examination, routine EEG and/or EEG-video monitoring, brain MRI, laboratory tests. Therapy with antiepileptic drugs was maintained throughout the study period. All patients were followed-up for at least 1 year.</p></sec><sec><title>Results</title><p>Results. Cessation of seizures was observed in 36.2% of patients and a &gt;50% reduction in seizure frequency – in 32.5% of patients. The occurrence of side effects of antiepileptic drugs decreased from 56.6% to 26.5%.</p></sec><sec><title>Conclusion</title><p>Conclusion. The introduction into clinical practice of methods for assessing the factors impacting the treatment outcome in patients with focal epilepsy will allow for monitoring of the treatment efficacy and improve the patient quality of life.</p><p>The authors declare the absence of conflict of interest with respect to this publication. All authors contributed equally to this article.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Цель – определение факторов, влияющих на эффективность лечения больных с фокальными эпилепсиями.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Дизайн исследования: проспективное, сравнительное, наблюдательное исследование в условиях реальной клинической практики. Критерии включения: возраст старше 18 лет; наличие двух и более эпилептических приступов с фокальным началом в анамнезе; наличие эпилептических приступов на момент первичного осмотра. Критерии исключения: наличие в анамнезе неэпилептических приступов любой этиологии; невозможность выполнить МРТ и/или ЭЭГ. Осуществлялся «первичный» осмотр и через 3-12 месяцев – «повторный» осмотр. Было обследовано 83 пациента с фокальной эпилепсией, имеющих приступы на момент первичного осмотра, 37 мужчин и 46 женщин в возрасте от 19 до 70 лет. Обследование включало сбор анамнеза, анализ дневника приступов, клинический и неврологический осмотр, рутинную ЭЭГ и/или ЭЭГ-видеомониторинг, МРТ головного мозга, лабораторные анализы. Проводилась терапия антиэпилептическими препаратами. У всех больных был отслежен катамнез длительностью не менее 1 года.</p></sec><sec><title>Результаты</title><p>Результаты. Прекращение приступов было у 36,2% пациентов, уменьшение частоты приступов более чем на 50% – у 32,5. Частота побочных эффектов АЭП снизилась с 56,6% до 26,5%.</p></sec><sec><title>Заключение</title><p>Заключение. Введение в клиническую практику методик оценки факторов, влияющих на эффективность лечения больных с фокальными эпилепсиями, позволит осуществлять мониторинг лечебно-реабилитационных мероприятий и значительно улучшить качество жизни данных пациентов.</p><p>Авторы заявляют об отсутствии конфликта интересов в отношении данной публикации. Все авторы сделали эквивалентный вклад в подготовку публикации.</p></sec><sec><title> </title><p> </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>фокальная</kwd><kwd>эпилепсия</kwd><kwd>эффективность</kwd><kwd>лечение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>resistant</kwd><kwd>focal</kwd><kwd>epilepsy</kwd><kwd>efficacy</kwd><kwd>treatment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fisher R. S., Cross J. H., French J. A., Higurashi N., Hirsch E., Jansen F. E., Lagae L., Moshé S. L., Peltola J., Roulet Perez E., Scheffer I. E., Zuberi, S. M. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; https://doi.org/10.1111/epi.13670.</mixed-citation><mixed-citation xml:lang="en">Fisher R. S., Cross J. H., French J. A., Higurashi N., Hirsch E., Jansen F. E., Lagae L., Moshé S. L., Peltola J., Roulet Perez E., Scheffer I. E., Zuberi, S. M. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; https://doi.org/10.1111/epi.13670.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Scheffer I. E., Berkovic S., Capovilla G., Connolly M. B., French J., Guilhoto L., Hirsch E., Jain S., Mathern G. W., Moshé S. L., Nordli D. R., Perucca E., Tomson T., Wiebe S., Zhang Y.-H., Zuberi S. M. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; https://doi.org/10.1111/epi.13709 1-3.</mixed-citation><mixed-citation xml:lang="en">Scheffer I. E., Berkovic S., Capovilla G., Connolly M. B., French J., Guilhoto L., Hirsch E., Jain S., Mathern G. W., Moshé S. L., Nordli D. R., Perucca E., Tomson T., Wiebe S., Zhang Y.-H., Zuberi S. M. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; https://doi.org/10.1111/epi.13709 1-3.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Авакян Г. Н., Блинов Д. В., Лебедева А. В., Бурд С. Г., Авакян Г. Г. Классификация эпилепсии Международной Противоэпилептической Лиги: пересмотр и обновление 2017 года. Эпилепсия и пароксизмальные состояния. 2017; 9 (1): 6-25. https://doi.org/10.17749/2077-8333.2017.9.1.006-025.</mixed-citation><mixed-citation xml:lang="en">Avakyan G. N., Avakyan G. G. ILAE Classification of the epilepsies: the 2017 revision and update. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. 2017; 9 (1): 6-25 (in Russ.). https://doi.org/10.17749/2077-8333.2017.9.1.006-025.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Котов А.С. Комплаентность у больных эпилепсией. Журнал неврологии и психиатрии им. С.С. Корсакова. 2010; 110 (11): 46-48.</mixed-citation><mixed-citation xml:lang="en">Kotov A. S. Compliance in patients with epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry / Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (in Russ.). 2010; 110 (11): 46-48.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Котов А.С., Рудакова И.Г., Белова Ю.А. Предикторы эффективности лечения симптоматических и криптогенных парциальных эпилепсий у взрослых. Альманах клинической медицины. 2006; XIII: 49-55.</mixed-citation><mixed-citation xml:lang="en">Kotov A. S., Rudakova I. G., Belova Yu. A. Predictors of the effectiveness of treatment of symptomatic and cryptogenic partial epilepsy in adults. Almanac of clinical medicine. Al’manah klinicheskoj mediciny. 2006; XIII: 49-55 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Котов А.С. Предикторы фармакорезистентности эпилепсии у взрослых. Анналы клинической и экспериментальной неврологии. 2012; 6 (1): 25-31.</mixed-citation><mixed-citation xml:lang="en">Kotov A. S. Predictors of pharmacoresistance of epilepsy in adults. Annals of clinical and experimental neurology. Annaly klinicheskoj i jeksperimental’noj nevrologii (in Russ.). 2012; 6 (1): 25-31.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Котов А.С. Противоэпилептические препараты и аггравация приступов. Журнал неврологии и психиатрии им. С.С. Корсакова. 2014; 114 (11-2): 32-36.</mixed-citation><mixed-citation xml:lang="en">Kotov A. S. Antiepileptic drugs and aggravation of seizures. Journal of neurology and psychiatry. S. S. Korsakov / Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (in Russ.). 2014; 114 (11-2): 32-36.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Рудакова И.Г., Котов А.С., Белова Ю.А. Применение дженериковых препаратов в лечении эпилепсии на примере Топирамата. Журнал неврологии и психиатрии им. С.С. Корсакова. 2011; 111 (3): 38-43.</mixed-citation><mixed-citation xml:lang="en">Rudakova I. G., Kotov A. S., Belova Yu. a. the Use of generic drugs in the treatment of epilepsy on the example of Topiramate. Journal of neurology and psychiatry. S. S. Korsakov / Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (in Russ.). 2011; 111 (3): 38-43.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Котов А.С., Толстова Н.В. Провокаторы приступов у взрослых больных с симптоматическими и криптогенными фокальными эпилепсиями. Клиническая неврология. 2010; 1: 17-21.</mixed-citation><mixed-citation xml:lang="en">Kotov A. S., Tolstova N. In. Provokers of seizures in adult patients with symptomatic and cryptogenic focal epilepsy. Clinical neurology / Klinicheskaja nevrologija (in Russ.). 2010; 1: 17-21.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Henning O., Alfstad K.A., Nakken K.O., Lossius M.I. A call for better information about epilepsy: The patients’ perspective-An online survey. Seizure. 2019 Apr 27; 69: 173-179. https://doi.org/10.1016/j.seizure.2019.04.015. [Epub ahead of print] PubMed PMID: 31054491.</mixed-citation><mixed-citation xml:lang="en">Henning O., Alfstad K.A., Nakken K.O., Lossius M.I. A call for better information about epilepsy: The patients’ perspective-An online survey. Seizure. 2019 Apr 27; 69: 173-179. https://doi.org/10.1016/j.seizure.2019.04.015. [Epub ahead of print] PubMed PMID: 31054491.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Alshahrani A.M., Pathan A., Alruwais J.F., Alduhayshi A.M. Knowledge, attitude, and believes of epilepsy in local communities of Saudi Arabia. J Family Med Prim Care. 2019 Mar; 8 (3): 1065-1069. https://doi.org/10.4103/jfmpc.jfmpc_425_18. PubMed PMID: 31041252; PubMed Central PMCID: PMC6482760.</mixed-citation><mixed-citation xml:lang="en">Alshahrani A.M., Pathan A., Alruwais J.F., Alduhayshi A.M. Knowledge, attitude, and believes of epilepsy in local communities of Saudi Arabia. J Family Med Prim Care. 2019 Mar; 8 (3): 1065-1069. https://doi.org/10.4103/jfmpc.jfmpc_425_18. PubMed PMID: 31041252; PubMed Central PMCID: PMC6482760.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">McKenney J.M., Slining J.M., Henderson H.R. et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973; 48: 1104-1111.</mixed-citation><mixed-citation xml:lang="en">McKenney J.M., Slining J.M., Henderson H.R. et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973; 48: 1104-1111.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Urquhart J. Variable patient compliance in ambulatory trials – nuisance, threat, opportunity. J Antimicrob Chemother. 1993; 32: 643-649.</mixed-citation><mixed-citation xml:lang="en">Urquhart J. Variable patient compliance in ambulatory trials – nuisance, threat, opportunity. J Antimicrob Chemother. 1993; 32: 643-649.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
